Published in Br J Cancer on June 01, 1991
Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet (1975) 1.49
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. Ann Intern Med (1983) 1.23
Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol (1986) 1.19
Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood (1984) 1.10
Malignant lymphomas of follicular center cell origin in man. III. Prognostic features. Cancer (1979) 1.08
Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med (1986) 1.06
Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. Ann Intern Med (1986) 1.05
Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann Intern Med (1982) 1.03
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med (1977) 1.01
Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. Blood (1974) 1.00
Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer (1982) 0.94
Multivariate analysis of prognostic factors in the non-Hodgkin's malignant lymphomas. Cancer (1974) 0.90
A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol (1984) 0.89
Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification. Br J Cancer (1983) 0.88
Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables. Cancer (1984) 0.87
Recent trends in the treatment of non-Hodgkin's lymphomas. Eur J Cancer (1976) 0.87
Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer (1982) 0.87
COPBLAM III: infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol (1988) 0.86
Predictive model for prognosis in advanced diffuse histiocytic lymphoma. Cancer Res (1986) 0.84
A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications. Eur J Cancer Clin Oncol (1984) 0.84
Factors predicting for response and survival in adults with advanced non-Hodgkin's lymphoma. Arch Intern Med (1978) 0.83
Current status and perspectives in the treatment of non-Hodgkin's lymphomas. Eur J Cancer Clin Oncol (1984) 0.83
Interpretation of clinical trials in diffuse large-cell lymphoma. J Clin Oncol (1988) 0.78
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80
Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67
Day care after operations for hernia or varicose veins: a controlled trial. Br J Surg (1978) 4.30
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation (1998) 3.99
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (1995) 3.74
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26
Management of acute stroke in the elderly: preliminary results of a controlled trial. Br Med J (1980) 3.15
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ (1998) 2.73
Management of acute stroke in the elderly: follow-up of a controlled trial. Br Med J (1980) 2.67
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax (1996) 2.58
The prevalence of diabetic impotence. Diabetologia (1980) 2.47
Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res (1988) 2.40
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax (2000) 2.31
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg (2000) 2.30
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma (1992) 2.23
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol (1999) 2.13
Children, stress, and hospitalization: a field experiment. J Health Soc Behav (1968) 2.11
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol (1996) 2.05
Consumer acceptability of day care after operations for hernia or varicose veins. J Epidemiol Community Health (1978) 1.90
Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med (1991) 1.85
The clinical course and management of thoracic empyema. QJM (1996) 1.76
Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75
The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART) Eur Heart J (1999) 1.68
Bile acids in the diarrhoea of ileal resection. Gut (1973) 1.68
Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut (1980) 1.67
Evaluation of an automatic platelet counting system utilizing whole blood. J Clin Pathol (1972) 1.66
Predicting functional outcome following acute stroke using a standard clinical examination. Stroke (1982) 1.65
The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer (1994) 1.65
Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer (1996) 1.64
Does obesity compromise survival in women with breast cancer? Breast (2004) 1.63
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial. J Clin Oncol (1994) 1.58
Histology in breast cancer prognosis. Br J Cancer (1972) 1.58
Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg (1994) 1.57
Arthropathy, ankylosing spondylitis, and clubbing of fingers in ulcerative colitis. Gut (1970) 1.57
Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. Heart (2006) 1.55
A randomized trial comparing heater probe plus thrombin with heater probe plus placebo for bleeding peptic ulcer. Gastroenterology (2003) 1.54
Research: the community nurse and day surgery. Nurs Times (1980) 1.49
Predictable and unpredictable hazards of erythropoietic protoporphyria. Clin Exp Dermatol (1991) 1.49
Small-cell lung cancer after retinoblastoma. Lancet (1989) 1.48
Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. II. Extension of age range. Mutat Res (1989) 1.46
The natural history of low grade non-Hodgkin's lymphoma and the impact of a no initial treatment policy on survival. Q J Med (1991) 1.45
Immunoperoxidase staining of surface and intracellular immunoglobulin in human neoplastic lymphoid cells. J Clin Pathol (1980) 1.45
p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res (1993) 1.45
A study of eleven cutaneous malignant melanomas in adults with small-cell morphology: emphasis on diagnostic difficulties and unusual features. Histopathology (2002) 1.44
The cytological detection of persistent cervical intraepithelial neoplasia after local ablative treatment: a comparison of sampling devices. Br J Obstet Gynaecol (1992) 1.44
Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers. BMJ (1999) 1.44
A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Br J Obstet Gynaecol (1994) 1.44
Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years. J Natl Cancer Inst (2001) 1.44
Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol (1992) 1.43
Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry (1997) 1.43
Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: a placebo-controlled study. Respir Med (1996) 1.43
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health (1988) 1.41
The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial. Br J Dermatol (1984) 1.41
Antigens on human plasma cells identified by monoclonal antibodies. J Immunol (1983) 1.41
Digoxin and mortality in chronic heart failure. UK Heart Investigation. Lancet (1999) 1.40
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Popliteal vein reflux reduces the healing of chronic venous ulcer. Br J Surg (1998) 1.39
Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study. Br Med J (Clin Res Ed) (1981) 1.39
Functional assessment of patients undergoing day-care surgery for varicose veins or hernia: results from a randomised controlled trial. Health Bull (Edinb) (1979) 1.39
General practitioners' response to day care surgery. Practitioner (1978) 1.39
Autologous transfusion--too far, too soon? Vox Sang (1991) 1.38
Normal G2 chromosomal radiosensitivity and cell survival in the cancer family syndrome. Cancer Res (1988) 1.37
Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax (1985) 1.36
A clinical trial in the management of operable cancer of the breast. Br J Surg (1980) 1.35
Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax (1988) 1.33
Controlled trial of sotalol for one year after myocardial infarction. Lancet (1982) 1.32
Observer variation in the clinical assessment of stroke. Age Ageing (1976) 1.31
Tamoxifen as primary treatment of breast cancer in elderly or frail patients: a practical management. Br Med J (Clin Res Ed) (1985) 1.29
Does vasectomy accelerate testicular tumour? Importance of testicular examinations before and after vasectomy. BMJ (1990) 1.28
Aromatase inhibitors and arthralgia. J Clin Oncol (2001) 1.27
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial. Ann Oncol (1997) 1.26
The impact of chemotherapy on small cell carcinoma of the bronchus. Q J Med (1986) 1.26
Faecal stasis and diverticular disease in ulcerative colitis. Gut (1970) 1.23
Information giving in oncology: a preliminary study of tape-recorder use. Br J Clin Psychol (1992) 1.22
The treatment of operable cancer of the breast: A clinical trial in the South-East region of Scotland. Br J Surg (1974) 1.20
Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene (1990) 1.19
Primary systemic therapy for operable breast cancer. Br J Cancer (1991) 1.19
Detection of breast disease in a family planning association clinic. Scott Med J (1976) 1.18
A controlled trial of weekly ultrasound therapy in chronic leg ulceration. Lancet (1987) 1.17
An experience of ulcerative colitis. 3. Long term outcome. Gastroenterology (1970) 1.13
Comparative evaluation of water recovery test and fluoroscopic screening in positioning a nasogastric tube during gastric secretory studies. Br Med J (1972) 1.12
Pseudopolyposis in ulcerative colitis. Lancet (1969) 1.12
Minimum effective dose of intermediate factor-VIII concentrate in haemophiliacs on home therapy. Lancet (1979) 1.11
Some blood plasma constituents correlate with human cataract. Br J Ophthalmol (1995) 1.11
Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med (1991) 1.09
The natural history of impotence in diabetic men. Diabetologia (1984) 1.08
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol (1984) 1.07
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. Br J Cancer (1997) 1.07
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther (2004) 1.07
Sarcoidosis: a disorder commoner in non-smokers? Thorax (1986) 1.06